Successful Completion of Series 2 Seed Round Funding

April 2023

Spoke Sciences is happy to announce the successful completion of our Series 2 seed round funding, marking a pivotal moment in our journey to redefine health and wellness. We are deeply grateful for the support and trust placed in us by our investors, who share our vision of revolutionizing the industry with plant-derived functional ingredients.

This achievement underscores our dedication to developing cutting-edge, plant-derived, functional ingredients. And this infusion of capital will empower us to amplify our research and development initiatives, further innovate our product lines, and strengthen our market presence. It also enables us to accelerate our mission to modernize the formulation and delivery of natural health solutions, promoting a healthier and more sustainable future for all.

The oversubscribed Series 2 seed round represents a resounding vote of confidence in our commitment to science-driven advancements. With this funding, we are poised to bring even more groundbreaking products to the market, enriching lives and setting new standards in the health and wellness sector. We're excited about the possibilities this investment unlocks as we continue on our path to transform the industry through innovative science.

Previous
Previous

IsoCaps™ Patent Application Published

Next
Next

Ben Franklin Technology Partners Invests as Part of Seed Funding Round